EPSRC Reference: |
GR/S00811/01 |
Title: |
Synthetic Studies on Dienediyne Chromoprotein Antibiotics |
Principal Investigator: |
Caddick, Professor S |
Other Investigators: |
|
Researcher Co-Investigators: |
|
Project Partners: |
|
Department: |
Chemistry |
Organisation: |
UCL |
Scheme: |
Standard Research (Pre-FEC) |
Starts: |
01 October 2003 |
Ends: |
31 March 2007 |
Value (£): |
229,303
|
EPSRC Research Topic Classifications: |
Biological & Medicinal Chem. |
|
|
EPSRC Industrial Sector Classifications: |
Chemicals |
Healthcare |
Pharmaceuticals and Biotechnology |
No relevance to Underpinning Sectors |
|
Related Grants: |
|
Panel History: |
|
Summary on Grant Application Form |
The dienediyne chromoprotein antibiotics are a class of highly reactive and potent anticancer agents which have found use in the clinic for the treatment of pancreatic cancer. These natural products are isolated from soil bacteria as a natural complex comprising the chromophore non-covalently bound to the apoprotein. The purpose of this project is to assemble core sub-structures of the dienediynes using novel radical, metathesis and aldol chemistry. Recombinant technology has been used to provide access to the apo-protein of NCS and this will be utilised to stablise late-stage intermediates in the planned synthesis of Neocarzinostatin, this would be a novel approach to total synthesis. The work will develop new methods for synthesis and will also underpin ongoing biological studies.
|
Key Findings |
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
Potential use in non-academic contexts |
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
Impacts |
Description |
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk |
Summary |
|
Date Materialised |
|
|
Sectors submitted by the Researcher |
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
Project URL: |
|
Further Information: |
|
Organisation Website: |
|